02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HEPATOLOGY, VOLUME 62, NUMBER 1 (SUPPL) AASLD ABSTRACTS 605A<br />

William M. Rosenberg - Advisory Committees or Review Panels: Janssen, Merk,<br />

Gilead, Merk, Gilead, GSK; Board Membership: iQur Limited, iQur Limited;<br />

Consulting: siemens; Speaking and Teaching: siemens, Roche<br />

The following authors have nothing to disclose: Brian J. Hogan, James O’Beirne,<br />

David W. Patch, Dominic Yu, Ioanna Parisi, Andrew R. Hall, Ankur Srivastava,<br />

Paul M. Trembling, Sudeep Tanwar<br />

794<br />

Association of skin capsular distance with accuracy<br />

of liver stiffness measurements of the FibroScan XL<br />

probe—comparison with virtual touch quantification<br />

and the FibroScan M probe<br />

Erina Kumagai 1,3 , Keiko Korenaga 2 , Masaaki Korenaga 1,2 ,<br />

Misuzu Ueyama 1,3 , Yoshihiko Aoki 2 , Yoko Yamagiwa 1 , Masatoshi<br />

Imamura 2 , Kazumoto Murata 1,2 , Tatsuya Kanto 1,2 , Naohiko<br />

Masaki 1,2 , Sumio Watanabe 3 , Masashi Mizokami 1,2 ; 1 The<br />

Research Center for Hepatitis and Immunology, National Center<br />

for Global Health and Medicine at Kohnodai, Ichikawa, Japan;<br />

2 Department of Gastroenterology and Hepatology, Kohnodai Hospital,<br />

National Center for Global Health and Medicine, Ichikawa,<br />

Japan; 3 Department of Gastroenterology, Juntendo University<br />

School of Medicine, Bunkyo-ku, Japan<br />

Background and Aim: The FibroScan XL probe was specifically<br />

designed for obese patients. However, there is no data<br />

regarding its use in Japanese individuals, who tend to be less<br />

obese than Caucasians. This study evaluates the diagnostic<br />

performance of the XL probe, the FibroScan M probe, and the<br />

virtual touch quantification (VTQ) method in Japanese patients<br />

with chronic liver disease. Methods: A total of 664 consecutive<br />

patients with chronic liver disease who underwent ultrasonography<br />

were prospectively enrolled from June through October<br />

2014. The cause of liver disease was hepatitis C virus (HCV,<br />

n = 179), hepatitis B virus (HBV, n = 79), fatty liver (n = 264),<br />

or non-HBV non-HCV hepatitis (n = 142). Liver stiffness was<br />

measured by VTQ, the M probe, and the XL probe on the same<br />

day. Liver stiffness measurement (LSM) failure was defined as<br />

zero valid shots; unreliable examination was defined as

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!